Effects of Disulfiram on Apoptosis in PANC-1 Human Pancreatic Cancer Cell Line

Overview

Journal Res Pharm Sci

Specialty Chemistry

Date 2015 Feb 7

PMID 25657800

Citations 11

Authors

M Nikbakht Dastjerdi

Z Babazadeh

M Rabbani

M Gharagozloo

A Esmaeili

M Narimani

Affiliations

Soon will be listed here.

Abstract

Pancreatic carcinoma is currently considered as a rapidly progressive and fatal disease, and is typically diagnosed late in its natural course. It is characterized by a poor diagnosis and lack of response to conventional therapy. Recent studies have suggested that disulfiram (DSF), a member of the dithiocarbamate family, may have antitumor activity. This study aimed to evaluate the in vitro effect of DSF on apoptosis in human pancreatic cancerous cell line (PANC-1). PANC-1 cells were cultured and treated with DSF at doses of 5, 10, 13 μM for 24 h and apoptosis was measured. Methylation specific PCR (MS-PCR) and real-time quantitative PCR were carried out to detect the methylation pattern and to estimate the mRNA expression levels of RASSF1A, p21 and Bax. MS-PCR analysis demonstrated that no unmethylated band was apeared in PANC-1 cell line after DSF treatments. The real-time quantitative PCR results showed no significant mRNA expression for RASSF1A (p>0.05); whereas p21 and Bax expression were significantly (p<0.01) enhanced after treatment with DSF. The results of the current study indicated that DSF can induce appoptosis in PANC-1 through p21 and Bax pathway but not through RASSF1A.

Citing Articles

Anticancer effects of disulfiram: a systematic review of in vitro, animal, and human studies.

Wang L, Yu Y, Zhou C, Wan R, Li Y Syst Rev. 2022; 11(1):109.

PMID: 35655266 PMC: 9161604. DOI: 10.1186/s13643-021-01858-4.

Disulfiram Alone Functions as a Radiosensitizer for Pancreatic Cancer Both and .

Xu Y, Lu L, Luo J, Wang L, Zhang Q, Cao J Front Oncol. 2021; 11:683695.

PMID: 34631519 PMC: 8494980. DOI: 10.3389/fonc.2021.683695.

Effect of vorinostat on INK4 family and HDACs 1, 2, and 3 in pancreatic cancer and hepatocellular carcinoma.

Sanaei M, Kavoosi F Res Pharm Sci. 2021; 16(3):260-268.

PMID: 34221059 PMC: 8216159. DOI: 10.4103/1735-5362.314824.

The Combination of Metformin and Disulfiram-Cu for Effective Radiosensitization on Glioblastoma Cells.

Rezaei N, Neshasteh-Riz A, Mazaheri Z, Koosha F, Hoormand M Cell J. 2019; 22(3):263-272.

PMID: 31863651 PMC: 6947006. DOI: 10.22074/cellj.2020.6798.

Ketamine exerts a protective role in a cell-based model of major depressive disorder via the inhibition of apoptosis and inflammation and activation of the Krebs cycle.

Zhang W, Sun Q, Jia L, Li M Bosn J Basic Med Sci. 2019; 20(1):44-55.

PMID: 31215856 PMC: 7029208. DOI: 10.17305/bjbms.2019.4222.

References

Lloyd A, Obermuller F, Staddon S, Barth C, McMahon M, Land H . Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 1997; 11(5):663-77. DOI: 10.1101/gad.11.5.663. View

Roper E, WEINBERG W, Watt F, Land H . p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes. EMBO Rep. 2001; 2(2):145-50. PMC: 1083816. DOI: 10.1093/embo-reports/kve020. View

Arlt A, Muerkoster S, Schafer H . Targeting apoptosis pathways in pancreatic cancer. Cancer Lett. 2010; 332(2):346-58. DOI: 10.1016/j.canlet.2010.10.015. View

Hariharan D, Saied A, Kocher H . Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford). 2008; 10(1):58-62. PMC: 2504856. DOI: 10.1080/13651820701883148. View

Zhang X, Yashiro M, Ohira M, Ren J, Hirakawa K . Synergic antiproliferative effect of DNA methyltransferase inhibitor in combination with anticancer drugs in gastric carcinoma. Cancer Sci. 2006; 97(9):938-44. PMC: 11158058. DOI: 10.1111/j.1349-7006.2006.00253.x. View

Donninger H, Vos M, Clark G . The RASSF1A tumor suppressor. J Cell Sci. 2007; 120(Pt 18):3163-72. DOI: 10.1242/jcs.010389. View

Lyko F, Brown R . DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst. 2005; 97(20):1498-506. DOI: 10.1093/jnci/dji311. View

Wang T, Liu H, Chen Y, Liu W, Yu J, Wu G . Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2010; 28:160. PMC: 2809060. DOI: 10.1186/1756-9966-28-160. View

Chung K, Park J, Kim C, Lee H, Sato N, Uchiyama Y . Novel biphasic effect of pyrrolidine dithiocarbamate on neuronal cell viability is mediated by the differential regulation of intracellular zinc and copper ion levels, NF-kappaB, and MAP kinases. J Neurosci Res. 2000; 59(1):117-25. View

10.

Dastjerdi M, Salahshoor M, Mardani M, Rabbani M, Hashemibeni B, Gharagozloo M . The apoptotic effects of sirtuin1 inhibitor on the MCF-7 and MRC-5 cell lines. Res Pharm Sci. 2013; 8(2):79-89. PMC: 3764679. View

11.

Guo X, Xu B, Pandey S, Goessl E, Brown J, Armesilla A . Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. Cancer Lett. 2009; 290(1):104-13. DOI: 10.1016/j.canlet.2009.09.002. View

12.

Bird A . Perceptions of epigenetics. Nature. 2007; 447(7143):396-8. DOI: 10.1038/nature05913. View

13.

Kabiri A, Esfandiari E, Hashemibeni B, Kazemi M, Mardani M, Esmaeili A . Effects of FGF-2 on human adipose tissue derived adult stem cells morphology and chondrogenesis enhancement in Transwell culture. Biochem Biophys Res Commun. 2012; 424(2):234-8. DOI: 10.1016/j.bbrc.2012.06.082. View

14.

Thaler S, Hahnel P, Schad A, Dammann R, Schuler M . RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res. 2009; 69(5):1748-57. DOI: 10.1158/0008-5472.CAN-08-1377. View

15.

Eneanya D, BIANCHINE J, Duran D, Andresen B . The actions of metabolic fate of disulfiram. Annu Rev Pharmacol Toxicol. 1981; 21:575-96. DOI: 10.1146/annurev.pa.21.040181.003043. View

16.

Lowe S, Cepero E, Evan G . Intrinsic tumour suppression. Nature. 2004; 432(7015):307-15. DOI: 10.1038/nature03098. View

17.

Avramouli A, Tsochas S, Mandala E, Katodritou E, Ioannou M, Ritis K . Methylation status of RASSF1A in patients with chronic myeloid leukemia. Leuk Res. 2009; 33(8):1130-2. DOI: 10.1016/j.leukres.2009.01.003. View

18.

Lin J, Haffner M, Zhang Y, Lee B, Brennen W, Britton J . Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth. Prostate. 2010; 71(4):333-43. PMC: 3043358. DOI: 10.1002/pros.21247. View

19.

Veverka K, Johnson K, Mays D, Lipsky J, Naylor S . Inhibition of aldehyde dehydrogenase by disulfiram and its metabolite methyl diethylthiocarbamoyl-sulfoxide. Biochem Pharmacol. 1997; 53(4):511-8. DOI: 10.1016/s0006-2952(96)00767-8. View

20.

Esteller M . Epigenetics in cancer. N Engl J Med. 2008; 358(11):1148-59. DOI: 10.1056/NEJMra072067. View